Primer on the Economics of Antimicrobial Resistance

Abstract

Antimicrobial resistance is a global issue that threatens to alter the treatment and management of infections. For many decades, antibiotics have successfully kept numerous bacterial pathogens at bay and have reduced post-surgery infection rates. This article presents research and projections on the economic implications of antimicrobial resistance. Development of new antibiotics comes at a substantial cost. The economic incentives of different stakeholders affected by antimicrobial resistance are also discussed.